Loading clinical trials...

A Study of LY2940094 in Participants With Alcohol Dependency | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT01798303

A Study of LY2940094 in Participants With Alcohol Dependency

The main purpose of this study is to evaluate a once daily (QD) 40-milligram (mg) oral dose of LY2940094 in participants with an alcohol dependency to evaluate if LY2940094 will reduce alcohol drinkin...

Lead sponsor: BlackThorn Therapeutics, Inc.•5 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

SMART-r: Substance Monitoring and Active Relapse Tracking Repository

NCT06676059 · Alcoholism, Substance-Related Disorders

RECRUITINGPhase 2

Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

NCT06939088 · Alcohol Use Disorder, Alcohol Abuse/Dependence, and more

RECRUITINGNA

Alcohol Misuse Treatment to Patients Newly Diagnosed With Alcohol-related Liver Disease: a Randomized Controlled Trial

NCT06493773 · Liver Diseases, Alcoholic, Alcohol Use Disorder, and more

RECRUITINGNA

Effectiveness of High-frequency rTMS in Reducing Alcohol Consumption in Non-abstinent Patients With an Alcohol Use Disorder

NCT04773691 · Alcoholism, rTMS Stimulation

RECRUITINGNA

Comparing Combined Behavioral Intervention and Ericksonian Hypnotherapy for Alcohol Addiction

NCT06916754 · Alcohol-Related Disorders, Alcoholism, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 3, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment88

Start dateJul 2013

Last updatedFeb 3, 2017

Condition

Alcoholism

Locations shown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

New Haven, Connecticut

North Miami, Florida

Indianapolis, Indiana

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 3, 2017Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study of LY2940094 in Participants With Alcohol Dependency

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

SMART-r: Substance Monitoring and Active Relapse Tracking Repository

Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

Alcohol Misuse Treatment to Patients Newly Diagnosed With Alcohol-related Liver Disease: a Randomized Controlled Trial

Effectiveness of High-frequency rTMS in Reducing Alcohol Consumption in Non-abstinent Patients With an Alcohol Use Disorder

Comparing Combined Behavioral Intervention and Ericksonian Hypnotherapy for Alcohol Addiction

Trial snapshot

Condition

Locations shown

For caregivers